Brand name
Tregzi, the original
We didn’t find a savings card or cash price from Tregzi’s maker. Ask the pharmacy for Tregzi’s cash price. With insurance, ask what your plan charges.
Generic name: allogeneic regulatory T cell immunotherapy with hspc and T cells-vldq
Used for: Stem cell transplant for blood cancers
Ask for the cash price
Tregzi
Tregzi is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
Tregzi, the original
We didn’t find a savings card or cash price from Tregzi’s maker. Ask the pharmacy for Tregzi’s cash price. With insurance, ask what your plan charges.
There isn’t one.
Tregzi is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
TREGZI™ is an allogeneic regulatory T cell-based immunotherapy with hematopoietic stem and progenitor cells and T cells indicated for use in matched donor hematopoietic stem cell transplantation with myeloablative preparative regimen, for hematopoietic and immunologic reconstitution and to improve chronic graft-versus-host disease (cGVHD)-free survival, in the treatment of adults with hematological malignancies.
Source: the FDA label for Tregzi (Orca Biosystems Inc.), June 30, 2026. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/tregzi/